Item 2.02 Results of Operations and Financial Condition



On August 5, 2021, Xeris Pharmaceuticals, Inc. (the "Company") issued a press
release containing information about the Company's results of operations and
business highlights for the three and six months ended June 30, 2021. A copy of
this press release is furnished as Exhibit 99.1 to this Current Report on Form
8-K.
The information in this Form 8-K (including Exhibit 99.1) shall not be deemed
"filed" for purposes of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits:
Exhibit Number                   Description
                                   Press release issued by Xeris Pharmaceuticals, Inc. dated August 5,
99.1                             2021.
                                 Cover Page Interactive Data File (embedded within the Inline XBRL
104                              document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses